Domicile
Reels
Groupes
Pages
Plus
Groupes Pages Evènements Blogs Offres Emplois Courses Forums Film Merits
Se connecter S’enregistrer
Sélecteur de thème
Mode nuit
FDA/EMA Fast-Track Approvals Accelerate Lung Cancer Drug Launches: 15 New Therapies Expected by 2028, Market Report Reveals
Regulatory agencies like the FDA and EMA are accelerating approvals for lung cancer therapies, driven by urgent unmet needs and advancements in real-world evidence (RWE). These policy shifts are reshaping the market, reducing time-to-market for new drugs and encouraging innovation in underserved subtypes. The Lung Cancer Therapeutics Market, valued at $35 billion in 2023, is set to welcome 15...
0 Commentaires ·0 Parts ·113 Vue ·0 Aperçu
Connectez-vous pour aimer, partager et commenter!